000538.SZ · 云南白药
China A-shares · RS rating 84 · As of 2026-10-14
| Price | 52.65 CNY |
|---|---|
| 1-day change | +1.3% |
| RS rating (overall / 1M / 3M / 12M) | 84 / 87 / 72 / 59 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 34 / 38 / 27 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -11.4% |
| Distance from 52-week high | +9.1% |
| Market cap (USD) | $13.7B |